Anthropic collaborates with six institutions including Bristol-Myers Squibb to launch AI drug discovery and develop treatments for rare diseases

Anthropic's life science team collaborates with Bristol-Myers Squibb, Generate Biomedicines, and six other institutions to launch an AI drug discovery project, with the first focus on rare childhood muscular dystrophy, with Claude handling most of the scientific and operational work.